Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
about
Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine DevelopmentConsensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cellsHuman immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceRegulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag geneEnhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designMultiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityEnhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 GMagnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?Phylogenetic mapping of recombination hotspots in human immunodeficiency virus via spatially smoothed change-point processes.Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
P2860
Q27477561-790FB92C-7ACD-41D9-A916-882F2A64EE09Q28487823-962BE654-68E6-4F2A-8AF8-F79ABF97B6E3Q33707543-E520B8D1-1F5B-4692-B706-F97AE915E149Q33717736-253C521B-B4ED-47DF-8EE2-F1DFF530D3B6Q33763297-ABF377DD-C5DD-4626-A691-A930C3604143Q33799802-876F5FD4-3386-4405-9BB0-5BA282D844BBQ33806715-2EAA0C81-2A0E-41DC-A52D-A418F34CD556Q33822789-A26B889F-7A44-48F4-9087-F072D4E81289Q33845527-4FC5ADF0-A8C8-43FD-BFB4-3DEAB29FE476Q33849127-E34F094D-956B-496F-92B6-0693AD2513DDQ33854615-AF47D0CC-D78E-4563-9155-1DC7705896FFQ34186587-EAEEE491-9978-4845-9997-BC6E75EC35B9Q34342982-17C05F43-0C2D-4D5E-AE1D-91C21977CA2DQ34348269-843BA66D-16E3-4163-8534-6D16A56F4E23Q34364357-D382AEFA-6868-49E8-AD28-BFD4B630DB30Q35757775-257EF322-9251-4AE0-80BD-534E2C3117E1Q36474235-E28FCF17-6D7D-4458-950C-E97A65AE1E21Q37511451-E4C891FE-AFFA-4CDE-940A-A90238585393Q37568289-9697AE41-7CE4-4004-BB22-460D10A84299Q39602888-D9231F5E-6753-4CAC-872A-10EAAB43E825
P2860
Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cross-reactions between the cy ...... African and European patients.
@ast
Cross-reactions between the cy ...... African and European patients.
@en
type
label
Cross-reactions between the cy ...... African and European patients.
@ast
Cross-reactions between the cy ...... African and European patients.
@en
prefLabel
Cross-reactions between the cy ...... African and European patients.
@ast
Cross-reactions between the cy ...... African and European patients.
@en
P2093
P2860
P1433
P1476
Cross-reactions between the cy ...... African and European patients.
@en
P2093
F Letourneur
S Saragosti
P2860
P304
P577
1998-05-01T00:00:00Z